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Poster Session I S235be a consideration in the pre-transplant evaluation. Studies are
needed to further delineate the immunologic impact of donor
serostatus.220
CMV SPECIFIC T CELLS PREVENT PROGRESSION FROM LOW TO HIGH
LEVEL VIREMIA IN D1R1 BUT NOT D-R1 PATIENTS
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Background:Cytomegalovirus (CMV) reactivates (becomes detect-
able in blood) in most seropositive hematopoietic cell transplant
(HCT) recipients. In some reactivating patients, low level viremia
(\ 50,000 DNA copies/ml plasma, ie, less than our institutional
threshold for preemtive therapy) progresses to high level viremia
or CMV disease, which is potentially fatal. We hypothesized that
low level viremia progresses in patients with low specific T cell
counts and spontaneously resolves in patients with high specific T
cell counts.
Methods: In 30 CMV seropositive HCT recipients monitored
weekly for reactivation by real-time PCR, blood was drawn for
specific T cell counts within 4 days from the first episode of
low level viremia. Fourteen patients received grafts from seropos-
itive donors (D1R1), and 16 patients from seronegative donors
(D-R1). Mononuclear cells were stimulated overnight with
CMV lysate, pp65 overlapping peptides, no stimulus (negative
control) or staphylococcal enterotoxin B (positive control). T cells
producing IFNg, TNFa and/or IL2 were enumerated by flow cy-
tometry.
Results: Among D1R1 patients, counts of CMV lysate and pp65
specific CD4 T cells producing IFNg and TNFa (and not IL2)
were higher in patients with spontaneous resolution than patients
with progression (p 5 0.02 for CMV lysate, p 5 0.004 for pp65).
Also, there was an inverse correlation between pp65 specific CD8
T cells producing IFNg and TNFa and peak viremia (r 5 -0.94, p
5 0.005) in D1R1 patients who progressed to high level viremia/
disease. In contrast, among D-R1 patients, CMV lysate and pp65
specific T cell counts were similar in patients with spontaneous res-
olution and patients with progression, and there was no correlation
between specific T cell counts and peak viremia.
Conclusion:CMV specific T cells play a role in preventing progres-
sion from low to high level CMV reactivation/disease in D1R1
patients. Other immune mechanisms (eg, NK cells?) play the role
in D-R1 patients.221
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Introduction: Hematopoietic stem cell transplantation (HSCT)
has been used as a treatment for hematologic malignancies and
non-malignant disorders. The success of engraftment is important
for determining the direction of treatment and the prognosis
of patients. Various methods of early assessment have been
proposed. The purpose of this study was to evaluate immature
reticulocyte fraction (IRF) as an early predictor of marrow
engraftment and to validate cut-off values for IRF in pediatric
patients.
Patients and Methods: Retrospective analysis was performed on
172 patients including 108 males (62.8%) and 64 females
(37.2%) with a median age of 8.3 years who underwent HSCT
(autologous: 87 patients, allogeneic: 85 patients) in Seoul Na-
tional University Children’s hospital from January 1st, 2005 toDecember 31st, 2008. Complete blood counts with reticulocyte
parameters were measured in all patients. The day of engraftment
of neutrophil was defined as the first of three consecutive days of
an absolute neutrophil count . 500 /mL with GCSF support. En-
graftment of platelets was defined as an unsupported platelet
count over 20,000/mL for seven days.
Results: Standard neutrophil engraftment occurred after a mean of
12.164.3 days following HSCT and platelet engraftment occurred
after a mean of 19.4611.7 days. With regards to IRF, mean rates
were as follows: above 1% after 9.662.6 days, above 3.5% after
10.563.0 days, and above 5% after 11.163.6 days. These differences
was statistically significanct for IRF and platelets when compared
with standard neutrophil recovery after HSCT. Following HSCT,
themean day on which IRF increased above 3.5% preceded the stan-
dard neutrophil engraftment day (P\0.001). The predicting cut-off
value of IRF was 3.5% (AUC 5 0.879, 95% CI, 0.759-0.999) at 8
days after HSCT. Sensitivity and specificity were 86.7% and
82.8%, respectively.
Conclusions: Considering these results of the increase in IRF
preceded that of absolute neutrophil count (ANC) or platelets
in most cases, IRF was useful as an early indicator of marrow en-
graftment especially when observed simultaneously with the other
parameters.222
EXTRATHYMIC SITES DRIVE THYMUS-INDEPENDENT DEVELOPMENT OF
FUNCTIONAL T CELLS AFTER BONE MARROW TRANSPLANTATION
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T cell deficiency after bone marrow transplantation (BMT) leads
to significant morbidity andmortality due to infection andmalignant
relapse. We have previously shown that CD4-CD8- T cell precur-
sors (preT) generated via OP9-DL1 coculture improve thymic and
peripheral T cell reconstitution when administered at the time of
BMT. While the thymus supports T cell development into old
age, adult BMT recipients have limited thymic function due to
age-related involution and additional injury caused by transplant
conditioning. We therefore hypothesized that T cell reconstitution
after BMT may depend to some extent on extrathymic T cell
development, which has previously been described as present but
abnormal.
We found that, in addition to the thymus, preT cells engrafted in
extrathymic sites, including mesenteric lymph nodes (MLN), pe-
ripheral lymph nodes (PLN) and spleen, within 24 hours of transfer
into euthymic BMT recipients. We detected CD41CD81 (double
positive, DP) thymocyte-like cells of both preT and bone marrow
(BM) origin in MLN, but not PLN, BM, or spleen, suggesting T
cell development in MLN. Using a novel dual reporter for biolumi-
nescence imaging we confirmed that preT trafficked to gut-associ-
ated tissues, where they underwent NFAT activation, consistent
with T cell development. In competitive reconstitution studies we
found that engraftment of preT in thymic and extrathymic sites re-
quired PSGL-1, while CCR9 may be dispensable.
To better study extrathymic T cell development, we transferred
preT into thymectomized or athymic BMT recipients. We demon-
strated that preT and BM cells develop into both TCRab and
TCRgd T cells in athymic BMT recipients. As in euthymic recipi-
ents, preT engraft in extrathymic gut-associated sites andMLN sup-
port DP early after transfer into athymic BMT recipients.We found
more CD41, CD8ab1, and CD8aa1 T cells in the spleen, PLN,
MLN, and Peyer’s patches of athymic BMT recipients that received
preT than in nontransplanted or BM only recipients. Extrathymic-
derived CD41 and CD8ab1T cells are naive CD44- cells with a di-
verse T cell receptor (TCR) repertoire. In addition, extrathymic-de-
rivedT cells proliferated to a similar extent as thymic-derived T cells
and produced IFNg and TNFa following in vitro stimulation. In
conclusion, using adoptively transferred preT, we have
